NasdaqGS - Delayed Quote USD
Cullinan Therapeutics, Inc. (CGEM)
17.30 +2.27 (+15.10%)
At close: June 22 at 4:00:01 PM EDT
16.99 -0.31 (-1.79%)
Pre-Market: 7:28:23 AM EDT
Trade CGEM on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for CGEM
- Previous Close
15.03 - Open
15.27 - Bid 12.39 x 200
- Ask 19.69 x 200
- Day's Range
15.26 - 17.40 - 52 Week Range
5.68 - 17.40 - Volume
1,495,481 - Avg. Volume
1,026,182 - Market Cap (intraday)
1.063B - Beta (5Y Monthly) 0.01
- PE Ratio (TTM)
-- - EPS (TTM)
-3.37 - Earnings Date (est.) Aug 6, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
31.55
Recent News
View More
Performance Overview
Trailing total returns as of 6/22/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
CGEM
67.15%
S&P 500 (^GSPC)
9.16%
1-Year Return
CGEM
125.55%
S&P 500 (^GSPC)
25.22%
3-Year Return
CGEM
39.63%
S&P 500 (^GSPC)
70.54%
5-Year Return
CGEM
30.69%
S&P 500 (^GSPC)
75.98%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/22/2026
Market Cap
1.06B
Enterprise Value
713.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.90
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.57%
Return on Equity (ttm)
-48.16%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-221.04M
Diluted EPS (ttm)
-3.37
Balance Sheet and Cash Flow
Total Cash (mrq)
351.88M
Total Debt/Equity (mrq)
0.65%
Levered Free Cash Flow (ttm)
-102.82M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreDaily – Vickers Top Buyers & Sellers for 06/24/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 05/17/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/07/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.